SmartZyme's Series B Round

SmartZyme raised a round of funding on March 14, 2018.

SmartZyme is a privately held biopharmaceutical company focused on its Provolution technological platform for protein design and engineering, in accordance with industry specifications. The company ai…

Articles about SmartZyme's Series B Round: